医学
强直性脊柱炎
内科学
生物制剂
物理疗法
重症监护医学
类风湿性关节炎
作者
Philip J. Mease,Taylor Blachley,William N. Malatestinic,Leslie R. Harrold,Blessing Dube,Jeffrey Lisse,Rebecca Bolce,Theresa Hunter
标识
DOI：10.1080/03007995.2023.2291160
摘要
Objective To describe bDMARD initiators by biologic experience among ankylosing spondylitis (AS) patients and change in disease activity and patient-reported outcomes (PROs) in real-world US patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
杳鸢
不配.
YuanbinMao
乐乐乐乐乐乐
嗯哼
Endlessway
一一
完美的天空
8R60d8
36456657
xjcy
甜甜玫瑰
HCLonely
tuanheqi
精明的迎松
Billy
三新荞
子车茗
shinysparrow
pluto
皖公网安备34019202002308
